RxDoctor Payments Data

Tanesha Washington

Family · Gadsden, SCNPI 1811532278

Payments from drug & device makers

$159in general payments, 2019–2025

Across 9 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$34
  • Takeda Pharmaceuticals U.S.A., Inc.$31
  • Amgen$29
  • Bayer$25
  • Lundbeck LLC$21
  • Genentech USA, Inc.$18

What the payments were for

  • Food & beverage$159100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)2$34
Takeda Pharmaceuticals U.S.A., Inc.2$31
Amgen(2 entities)2$29
Bayer1$25
Lundbeck LLC1$21
Genentech USA, Inc.1$18

How this compares

$159 in reported general payments places this provider in the 30th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$3,707,813
Medicare patients
349
Services billed
108,579

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Gadsden

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →